ANGELALIGN (06699) issued a positive profit forecast, expecting a net profit of approximately $24 million to $25.4 million in the first half of the year, an increase of 69.0% to 78.9% compared to the same period last year.

date
22:23 31/07/2026
avatar
GMT Eight
Angelalign Technology (06699) announced that in the first half of 2026, the group expects to achieve total revenue of approximately USD 229 million to 231 million, an increase of 41.9% to 43.1% year-on-year; net profit is expected to be approximately USD 24 million to 25.4 million, an increase of 69.0% to 78.9% year-on-year. The total number of invisible orthodontic cases is approximately 316,600, an increase of 40.2% year-on-year; among them, the number of cases in the global market (excluding mainland China) has grown by 43.3% to approximately 168,000 cases, while the number of cases in the mainland China market has grown by approximately 36.8% to about 148,600 cases.
ANGELALIGN (06699) announced that in the first half of 2026, the group expects to achieve total revenue of approximately $229 million to $231 million, an increase of 41.9% to 43.1% year-on-year; net profit is expected to be around $24 million to $25.4 million, an increase of 69.0% to 78.9% year-on-year. The total number of invisible orthodontic cases is expected to reach approximately 316,600, a year-on-year increase of 40.2%; among these, the number of cases in the global market (excluding Mainland China) is expected to grow by 43.3% to approximately 168,000, while the number of cases in the Mainland China market is expected to increase by about 36.8% to approximately 148,600. The Board believes that the expected improvement in the group's performance is mainly attributed to: doctors at all levels in both global and domestic markets gradually shifting towards clinically effective and stable invisible orthodontic systems, allowing the group to continue to benefit; the specialized brands and international direct sales and service networks established through significant investment in previous years are beginning to release operational leverage, driving profitability improvements; and the open management culture integrating multinational technical talents and clinical knowledge is accelerating product and service innovation.